Tony Fauci also contributed by laundering gobs of taxpayer cash to Moderna through his National Institute of Allergy and Infectious Diseases (NIAID), which also received $25 million from the Defense Advanced Research Projects Agency (DARPA) back in 2013 to develop messenger RNA (mRNA) technology.
The Cambridge, Mass.-based pharmaceutical company was suffering greatly in 2018, prompting it to issue one of the biggest initial public offerings (IPOs) that year. After that, the cash really started flowing, leading the company to where it is today.
“At the time, the less than ten-year-old firm suddenly had a $7.5 billion valuation – all on approximately $200 million in revenues with roughly $475 million in operating expenses,” reports indicate.
“Fast forward to Q1 of 2021, the biotech company generated $1.73 billion in COVID-19 vaccine-related revenue and achieved profitability for the first time. Their annual forecast hits a staggering $19.2 billion thanks to the convergence of the pandemic and government subsidy.”
As we reported last summer, Moderna is nothing more than a pump-and-dump scam, just like most of the rest of the American stock market – except in this case, people are dying while having their DNA permanently destroyed through mRNA reprogramming.
Moderna CEO Stéphane Bancel admitted during a recent interview that up until the Chinese Virus plandemic, Moderna had never once run a single phase-three clinical study, nor did it ever get a product authorized by regulators. All of this changed, of course when the Trump administration paved the way for Moderna to become a financial superstar.
“Trump’s own Vaccine Czar owns a large slug of Moderna call options. Some have called for him to sell them because of the obvious conflict,” warned Mike Adams, the Health Ranger, last spring.
Trump gave billions to Moderna to unleash DNA-reprogramming mRNA injections
Last April, Moderna received yet another cash injection from the Department of Health and Human Services‘ (HHS) Biomedical Advanced Research and Development Authority (BARDA) for $483 million. Two months later, BARDA sent over another $472 million, and by August the company was gearing up to unleash its mRNA jab on the world, thanks to a Trump administration contract for an initial 100 million doses.
The Trump administration agreed to award Moderna $1.525 billion for these 100 million doses, with the option to purchase another 400 million doses later on down the road. This, by the way, is why this writer will often refer to them as “Trump Vaccines,” because they are just as much his as they are Fauci’s.
“We appreciate the confidence of the U.S. government in our mRNA vaccine platform and the continued support,” Bancel announced at the time, proud of his relationship with Trump.
“We are advancing the clinical development of mRNA-1273 with the ongoing Phase 3 study being conducted in collaboration with NIAID and BARDA. In parallel, we are scaling up our manufacturing capability with our strategic partners, Lonza, Catalent, and Rovi, to address this global health emergency with a safe and effective vaccine.”
Moderna’s expected $19.2 billion in revenue this year exceeds an earlier estimate of $18.4 billion. Either way, Moderna is rolling in the dough as tens of thousands of people who took its jabs are already rolling in their graves.
It is also important to note that Moderna is now sitting on a whopping $8 billion in cash, which begs the question: why is the federal government still subsidizing Moderna’s “KidCOVE” study on children?
The American system under both Democrats and Republicans is unspeakably evil, in case you have not figured that out yet.
The latest news about Chinese Virus injection deception can be found at ChemicalViolence.com.
Sources for this article include: